Adagio Medical Holdings Statistics
Total Valuation
ADGM has a market cap or net worth of $24.21 million. The enterprise value is $30.20 million.
Important Dates
The next estimated earnings date is Thursday, May 14, 2026, before market open.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ADGM has 22.21 million shares outstanding. The number of shares has increased by 147.85% in one year.
| Current Share Class | 22.21M |
| Shares Outstanding | 22.21M |
| Shares Change (YoY) | +147.85% |
| Shares Change (QoQ) | +30.96% |
| Owned by Insiders (%) | 1.36% |
| Owned by Institutions (%) | 11.02% |
| Float | 4.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.06 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.44, with a Debt / Equity ratio of 1.75.
| Current Ratio | 2.44 |
| Quick Ratio | 2.08 |
| Debt / Equity | 1.75 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.53 |
Financial Efficiency
Return on equity (ROE) is -155.25% and return on invested capital (ROIC) is -38.90%.
| Return on Equity (ROE) | -155.25% |
| Return on Assets (ROA) | -29.84% |
| Return on Invested Capital (ROIC) | -38.90% |
| Return on Capital Employed (ROCE) | -62.51% |
| Weighted Average Cost of Capital (WACC) | 7.27% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$313,550 |
| Employee Count | 80 |
| Asset Turnover | n/a |
| Inventory Turnover | 0.32 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.15% in the last 52 weeks. The beta is 0.04, so ADGM's price volatility has been lower than the market average.
| Beta (5Y) | 0.04 |
| 52-Week Price Change | -16.15% |
| 50-Day Moving Average | 1.17 |
| 200-Day Moving Average | 1.25 |
| Relative Strength Index (RSI) | 39.91 |
| Average Volume (20 Days) | 215,654 |
Short Selling Information
The latest short interest is 50,386, so 0.23% of the outstanding shares have been sold short.
| Short Interest | 50,386 |
| Short Previous Month | 24,396 |
| Short % of Shares Out | 0.23% |
| Short % of Float | 1.05% |
| Short Ratio (days to cover) | 0.28 |
Income Statement
| Revenue | n/a |
| Gross Profit | -684,000 |
| Operating Income | -21.89M |
| Pretax Income | -25.08M |
| Net Income | -25.08M |
| EBITDA | -20.92M |
| EBIT | -21.89M |
| Earnings Per Share (EPS) | -$1.51 |
Full Income StatementBalance Sheet
The company has $17.11 million in cash and $21.76 million in debt, giving a net cash position of -$4.65 million or -$0.21 per share.
| Cash & Cash Equivalents | 17.11M |
| Total Debt | 21.76M |
| Net Cash | -4.65M |
| Net Cash Per Share | -$0.21 |
| Equity (Book Value) | 12.40M |
| Book Value Per Share | 0.56 |
| Working Capital | 11.85M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$19.01 million and capital expenditures -$374,000, giving a free cash flow of -$19.39 million.
| Operating Cash Flow | -19.01M |
| Capital Expenditures | -374,000 |
| Depreciation & Amortization | 970,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -19.39M |
| FCF Per Share | -$0.87 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |